International Journal of Experimental Pathology
(company limited by guarantee)
Report and Financial Statements
for the vear ended 31 December 2020
Charity No. 231407
Company No. 3ii858

INTERNATIONAL JOURNAL OF EXPF.RIMF.NTAI_ PATHOI.OGY
Report and Financlal Statements for the year ended 31 December 2020
Contents
Page
Trustees. report
Independent examiner's report
Statement of financial activities
Balance sheet
Notes to the financial statements

tNTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Page I
Trustees, report (incorporating the directors, report) for
the year ended 31 December 2020
The Trustees. who are also directors of the charity for the purposes of the Companies Act, present
their annual report and accounis for ihe year ended 31 December 2020. The aecounls comply with
the Charities Act 2011, the Companies Act 2006. Ihe Memorandum and Articles of Association and
Accounting and Reporting by Charities.- Statement of Recommended Practice applicable lo charitics
prLpJring their accounts in accordance with ihe Financial Reporting Standard applicable in the UK
and Republic of Ireland (FRS 102) updated Oclober 2019.
Reference and Administrative information
Company Number
355858 IEnbyland and Wal¢s)
Registered Charity No.
231407
Directors and Members
of the Council (Trustees)
Professor I IAuder - Presidenl
Professor M Alison - Vice President
Professor G Mutphy" Sccrelary
Professor J Shaw
Professor R Goldi
Editor
Professor D R Katz
Regisl¢r¢d Office
28 Pheasanis Way
Rickmanswonh
Hertfordshire
WD3 7ES
Bankers
CAF Bank Limited
25 Kings Hill Avenue
Kings Hill
Wcst Malling
Keni
ME194JQ
Investment Managers
Canaccord Genuity Wealth Managemenl
Slip House. Princes Drive
Worcester
WRI 2AB
Independent Examiner
Paul Harris
Paul Harris & Co Limited
59 I4'e51 End
Redruth
Cornwall
TR15 2SQ

tNTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Page 2
Trustee5' report {incorporating the directors, report) for
the year ended 31 December 2020 (continued)
Structure, Governance and Managemenl
Governing document
The charity is constituted as a company limited by guarantee, and is therefore governed by a
Meinorandum and Articles of Association. The liabilily of mcmbers in the ¢venl of a winding up is
limited to £ l O. Control of the company is vested in the Board of Trustees.
ReLruitment and appointment of Trustees
The Tru51ees are dlso directors of the company for the purposes of ihe Companies Aci and are
known as Members of the Council under ihe CQTnpany's Anicles of Associaiion. Under the
requirements of the Memorandum and Articles of Association, one fifth of the Members of the
Council must retire at each Annual General Meeiing. Ihese being (he members who hav¢ been in
O￿lle the long¢¥l. The retiring members are eligible for re-eleclion
In accordance with the Articles of Associalion. Professor l Lauder retires and offers himseir ror re-
election.
All Trusi¢es hav¢ ¢xp¢rtise in Ihe field ofexperimenthl pathology and when Truste¢s retire, Ihey are
replaced by persons wilh similar cxpertise. The Board has the power to appoint additional Trusiees
as it considers fit to do so.
All Trustees give of iheir time freely and no Truslee received remuneration in ihe year. Trnstees,
reimbursed travelling expenses are shown in Note 5 to ihe accounls.
bjeclives and activities
The charity's object and ils prinLiPdl actiN'ity conlinues to be Ihat of Ihe publication of the Journal.
Our policy is to publish research into the causL", diagnosis and cure of disease in man. and any
profils from such publicalion are used lo promoic rcscarch in Ihis field. The Truslees confirni that
they have considered the Charity Commission's public benefit guidance when reviewing the aims
lind objectives. MB PhD Fellowship award5 are made lo research inslituiions to fund nominated
sludLnts whose area of inleresl furtheis ihe objects of the charity. Sponsorship of an annual lecture
and prizes dre provided lo the Briiish SoLieiy for ￿ldtriA Biolog}
The type of material thai is published. including boih primary re%earch papers and reviews. is
subjeLI to peer review and is monitored by an Ediiorial Board. con)poscd of dn inlemalional group
of experts in the field of experimenlal paihology. IvhiLh meels Ihiee iitnes ¢d¢h year.
The Trustees meet as a Board of Dire¢lors to deiermine the general policy of the Journal. which has
remained unchanged.

tNTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Page 3
Trustees, report (incorporating the direetors, reportl for
the year ended 31 December 2020 (continued)
Achievements and performance
Joumal activities during 2020 continued on from previous years. with ihe continued smooth and
efficient support of the Editorial oifice Ims Biljana Nlikolic), which is a major Joumal as5el.
During 2020 360 manuscripls were handled of which 305 were new submissions. This represents an
increase of 131 papers over ihe previous year. Of these 43 /0 were from China. 120/0 from Brazil,
and >50/D from Turkey, UK, Egypt. India. Japan. Nigeria and Iran. 240 manuscripts were handled to
completion during 2020.
Acceptance rate was 15 % for the year overall (mean for previous 4 years 210/o}. During the first six
monihs of the year the acceptance rale was 510/0 (56 /0 in 2019} refle¢ling revised papers from the
previous year. There were several countries from iyhich one paper Wds submitted and accepled
giving l OOO/o acceplance. 25 papers were published and ihe lolal numb¢r of pages was 282. Mean
submi55ion lo first decision was 66 (lays. to final decision was 62 days and io acceptance was 17
days,. from ￿ ceipt at Wiley to early view wa5 62 days.
The Joumal is grateful for all the efforts made by referees during the year. 1.134 reviewer5 were
invited and 394 reviews were received. The median time to receipl of reviews is 13 days. Once
again the stalwarts have been among the Ediiorial Board members= Profs Alison. Corfe. Goldin.
Hoivie (A), Howie (S). Morgan. Silver and Ziats in particular. Others are Profs Brandner, Gilroy
and Holecek.
The Joumal 15 accessible to 7,420 subscrib¢rs, 99 /0 via Ihe Wiley Licence. Also during 2020
philanthropic initiatives extended low-cosi or free access to c￿￿ent content to 6.696 developing
world inslitulions, and Research4Life continues lo provide ei'en ivider access.
Review articles published during 2020 were:
ADAMTS-5.. A dI￿lcult leenager tuming 20. SaniamaTia S 101.4-20 2020
Preclinical r¢levanee of probiolics in type 2 diabetes.. A s>'slemalic rel'ie￿, AM Marques ¢1 al
101 ..68-79 2020
I'he cellular origins of cancer with particular referencc io Ihc gilstroinlestinal tract M R Alison l 01-.
132-512020
Download access to articles during 2020 was 450,000- 710/0 of these were from China, USA and
UK. The average number of downloads per article published in 2020 was 324 (compared 10 282
.across all Wiley journals in the same subject area.
The most frequenl downloads during 2020 were:
Experimental tnodels and methods for cutaneous wound healing assessment. Masson - Myers D ei
al 101.'21-37 2020
Origins of a pervasive, erroneous idea.. The "green birefringence" of Congo red-stained amyloid.
Howie A 100.4.. 208-212019
Extracellular matrix dynamics in cell migraiion. invasion and iissue morphogen¢sis. Yamada K et al
100.. 144-52 2019
An improved mouse model that rapidly develops fibrosis in non-alcoholic sieatohepatitis.
Matsurnoto M et al 94.. 93-103 2013
ADAMTS-5'. A ditricult ieenager turning 20. Santamaria S 101-4-20 2020

tNTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Page 4
Trustees, report (incorporating the directors, report) for
the year ended 31 December 2020 (continued)
Of these, the articles from Profs Howie and Yamada were published during ihe currenl impact factor
period. Four of the other five most frequent download5 were review articles from earlier i%%ues' the
fifth was to the recent review by Prof Alison.
The most frequent citations in the curreni impact factor calculation period were to the following
papers..
Charting the unexplored extracellular matrix in cancer T Cox 99=58-76 2018
Fcll Muir Leclure.- Collagen fibril formation in vitro and In vivo K Kadler 98=4-16 2017
Experimental lype 2 diabeles induciion reduces serum vaspin, bui noi scrum omentin, in Wistar rats
C A Castro el al 98..26-33 2017
Hcpaiocellular carcinoma in a mouse model fed a choline-deficient, L_amino acid-defined, high-fal
diet A Ikawa Yoshida 98.- 221-33 2017
Fell-muir Lecture.. Fibrillin microfibrils-. structural tensometers of elastic tissues? C Kiclty 98..172-
902017
The 2 year Itnpact Factor announced in 2020 was 1.672 (5 y¢&r 1.796).
Links with the British Sociei for Matrix Biolo
coniinued lo be excellent. led by Prof Couchman
and Midwood. This is reflected in the reviews. downloads and citations noted above.
Abstracis of the Autumn 2019 m¢¢ting'"Ccll Adhesion Networks in Hcalth and Disease" were
publishcd. Scveral meetings hav¢ bccn postponcd. bul ai ihe Autumn 2020 meeling priLes were
awarded 10 Alaa Al-shaer (Vancouver) for her ￿'ork on analysing the flexibility of collagen IV
int¢miplion sequences. Chris Derrick {Sheffield} for his ialk on the regulalion of cardiac growh by
laininins and Christine Chew (Manchester) for her presentation on kidney
macrophage heterogeneity and the contribution to mairix homcostasis.
Prof Andrew Pitsillides w&£ Fell_muir Lecturer for 2020.
MBPhD Lachmann Fellowshi
Cambridge.. Mr Eric Jou continued working on his lellowship during the 2019-20 academic year
under the supervision of Prof Andrew McKenzie.
Two new MBPhD Lachmann Fellowships were awarded.
Cambrid Fe.. Alex Fleet who is working on a projeci eniitled "Changes in the Oligodendrocyte
Pi'ogenitor Cell Nuclear LaTnina during Ageing" supervised by Dr Robin Franklin.
UCL.. Deborah Oluwadamilola Alawode who is workingF on a project entitled "Developing Novel
Sup¢r Sensitive Fluid Biomarker Assays in Neurodegencratii'e Diseases" supervised by Prof Henrik
Zellerberg (primary) and DrAmanda Heslegrave (subsidiary).
Fin9ncial review
The statement of financial a¢tivities on page 7 shows the financial results of the year's *lCtivities.
The balance sheet on page 8 shows the position al ihe year end. Nel revenue from the Joumal
increased by 50/D, while investment income decreased by 25010, mainly due to reductions in dividend
payments as a result of ihe pandemic. The charity conlinued ils support for the Fellowship award to
University of Cambridge. the annual Fcll Muir lecture and British Society of Matrix Biology pri7CS.
Further three-year funding awards wer¢ made lo University of Cambridge and UniN'ersity College
London togeih¢r with a new UCL Woolf pri7.e. The investment portfolio perfom)ed in line with
expectations, with nei unrealised gains of £40,998 over ihe year. Overall. the trnst¢¢s consider that
the charity is in a strong position lo continue lis work.

INTERNATIONALJOURNALOF EXPERIMENTAL PATHOLCQY
Trustees. report Oacorporathig the dlrectors. rep)rt) for
the yeAr ended 31 December 2020 (contlnued)
CoFld 19
Th¢ ch8rity'8 main sourc¢ of in¢ome frorn the journal has not been adversely impactsd by the
pandemi¢. There has been a decline in ini'estment income due ￿ reductions or cancellation of
dividends paid by compallie4 although the investment portfolio bas mBintained its value. The
Tn￿lee5 are satisfied that the clwity is largely shelterol from the etTects of Covid 19 in the short to
medium tern], due to its significant re8erves.
Page 5
Investment pomcy
Under the Memorandum and Articles ofAssociatiow the charity has the power to make any
investrnt which the Trustees see fit. The Trustees. policy for investing fimds is to geJMa* both
income and capital gmwth and the inv¢strnent portfolio is regularly reviewed for this purpos¢.
Ethical issu¢s ar¢ given due Lwideration wben investment decisions are made. Funds not required
for imtnediate use are invested in higher interest paying accounts. The Trustees consider the r¢turn
on investsuents in the year to be satisfa¢tory.
Reserves poll
Reserves are maintsined at levels whicb are necessary to supwrt th¢ continuatÈon of the publi¢ation
of the Journal and the F¢llowships awar￿1. The baI8nce on g¢ntt21 unrestrict¢d reserves at the year
end was £940,408.
Stxtsment of trnstees, res￿nSIbIlI￿¢S
Th¢ Trustee5 are required by law Èo prepare fin8ncial statements for each financial year whieh give
a true and fair view of the financiaI activities of the charity and of its fuwicial position at the end of
that year. In pr¢parin8 those finan¢ial ststements, the truste¢s are rquired to:
s¢Lect suitable accounting policies and apply them consistently.
' ll￿k¢ judgements and estimates that are reasonable and prudent.
• State whether the pK>licies adopted tre in accordance with the Companies Act 2(K)6 and with
applicable a¢counting stsnd8rds and st8*m¢nts of recommended practice, subject to any
material dePats￿ disclosed and explained in the financial statemell￿ and
' prepare the fu￿￿1&1 statfflnents on a going concern basis unIesg it Is inappropriat¢ to assume
that the charity will continue in operatio
Th¢ Trustee$ are responsible for keeping proper accounting re￿ which disclose with reasonable
accuracy at any time the financial position of the charity and e[￿1¢ them to ensure that the
rllwicial statements comply with the ComrAnies Act 2￿. They are also responsible for
safeguarding tlle assets of the cbarity and hence for tsking re&￿nable steps for the prevention and
detection of fraud and other ittegularÈties.
Sn￿ll ¢ompaDy provlilon8
This report bas been preptred in accordance with the provisions in Part 15 of the Conwanies Act
2Crf)6 applicable to comp8rries subject to the small companies re￿e.
This re￿rt was approved by the Board of Drectors and Trustees on 17 MaT¢h 2021 and Sign￿ oa
its behalf by:
Professor lan IAuder
Director and Truste¢

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Page 6
Independent examiner's reporl ¢0 ihe Trustees of International Journal of Experimental
Patholog!.
I report to the charity trLLStees on my examination of the accounts of th¢ ¢hatitabl¢ company for ihe year
ended 31 December 2020 which are set out on pages 7 to 12.
Responsibilities and basis of report
As the charity's trustees of the company {and also its directors for thc purwses of company law) you are
respotjsiblt for the preparation of the accounis in accordance with the requirementg of the Colnpanies Act
2006 ('the 2006 Act.).
Having been satisfied that the accounts of the cownpany are noi required io be audited under Part 16 of the
20Q6 Act and are eli¥ible for independent examination, I retK)rt in respect of my examination of your
charity s accounts as carried out under section 145 of the Charilies Act 2011 ('th¢ 201 l Art.). In carrying out
my examination I have folloi%red the D2rectioAs given by the Charity Commi55ion under section 145 (5) (b)
of the 2011 Act.
IndependeDt examiner's statement
I have ¢ompleted my exatnination_ I confirm thai no matters have come to my attenlion in connection with
the exaJninalioii giving me cause to believe..
{ l) accounting records were noi kept in respect of the company as required by S￿tiOn J86 of ihe 2(XJ6
Act.. or
{21 the accounts do not arcord with those rec(kr(ts- or
{3} the ac¢ounts do not complv with the acrounting requirements of section 396 of the 20￿ Act other
than any requirement rhat the accounts give a truc and fair. virw %vhi¢h ts not a matter considered as
part of an independeni examinatioii: or
(4) the accoun(s have noi been prepared in accordance with the methods and principles of the Stalejnenl
of Recommended Practice for accounling and reporting by cliarities applicable to charities preparing
their aceounis in accordanct with th¢ Financial Re￿rtIn￿ Standard applicable in the UK and
Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection wiih ihe examination lo which
attention should be drawli iii this report in order to enable a proper understsnding of the accounts to be
reached.
Paul Harris
Paul Harris & Co Limited
Chartered Certified Accountants
59 West End
Redruth
Cornwall
17 March 2021

tNTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Page 7
Statement of financial activities for the ve4r ended 31 December 2020
Income and expenditure account
Notes
2020
2019
Income from:
Charitable activities
41,054
39,080
Investments
29,101
38,873
Total income
70,155
77,953
Expenditure on:
Charilable aclivilies..
Research fellowship grants and prizes
Govcrnan¢c ¢0515
172.858
11.450
2,400
11,257
Total expendilure
184,308
13,657
Net (expendilure)/income befo￿ investmenl gain
(114,153) 64,296
Nct gain on investments
10
39,807
146,546
Net movemenl in funds
(74.346) 210,842
Reconciliation of funds:
Tulal funds brou￿1 torward
1,345.924 1,135,082
Total funds catTied forward
1,271,578 1,345,924
The notes on pages 9 to 12 fonn part of these financial statemenls.

tNTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Balance Sheet as at 31 De£ember 2020
Pa8e 8
Notes
2020
2019
Fixed assets
tnvestments
1,060,677
1,014,411
Current assets
Debtors
Jnvestments
Cash at bank
85,450
89,717
134.IKKI
209,477
238,627
Cttditors: amounts falling due
within one y¢2r
504.077
433,194
179,988
75285
Net current assets
324.089
357,909
Totsl 8ssets less cumt liabilities
Creditors: amounts fallin8 due
aftw one year
1.384.766
1,372,320
113.188
26,396
Net assets
1,271.578
1,345,924
Funds of the charity
Unrestricted fimds
General fimds
Fair value reserve
940,408
331,170
1,048.590
297,334
Total fimds
10
1271.578
1,345,924
The conyny was ¢ntitl¢d to exemption frorn audit under se¢tion 477 of the Companies Act 2006
Telating to small companies.
The members have not required the compauy to obtsin an audit of its accounts in accordance with
section 476 of the Cotnpanies Act 2(N)6.
The directo￿ acknowledge their responsibilities for complying with the r¢quirements of the
Companies Act with resp¢ct to accounting records and the pr¢parntion of a￿ounts.
These accounts have been prepared in accordance with the provisions applicable to sn7￿1
companies subject t() the small companies regill￿ and in 8ccorden¢e with FRS 102 SORP.
Approved by the Board of Dire¢tOTS and Trustees on 17 March 2021 and signed on its behalf.
Professor lan Lauder
Director and Tn￿te¢
The notes on pag¢s 9 to 12 forni part of these finan¢iaI statements.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Page 9
Notes to the accounts for the year ended 31 December 2020
Accounting policies
Basis of aceounting
The a¢¢ounts have been prepared under the historical Cost convention, with items recognised
at cost or transaction value, unless otherwise stared in the notes to these accounts.
The accounts have been prepared in accordance with the Statement of Recommended
Practice.. Accounting and Reporting by Charities preparing iheir accounts in accordance with
the Finxncial Reporting Standard applkcable in the UK and Republic of Ireland (FRS 102) -
(Charities SORP FRS 102) updated Ociober 2019, Ihe Financial Reporting Siandard
applicable in the UK and Republic of Ireland (FRS 102), the Charities Act 201 l and the
Companies Acl 2006.
The company Tneels the definition of a public benefit entily under FRS 102.
Income
Recognition of income..
These are included in the slalemenl or rinancial aclivilie5 ISOFAI when ihe charity becomes
entitled to the resources, il is Tnore likely than nol Ihal the Trusle¢s will receive the resources
and the monetary value can be tnea5ured wilh sU￿1Clent reliability.
Income from Ihe Journal:
This is th¢ Company's share of profit from Ihc publication of ihe Journal as shown in th¢
accounts produced by the Publisher and is recognis¢d when the charily has entiilemeni to the
funds.
Investment income..
This is includ¢d in the accounts when receipi is probable and the amounl receivable ¢an be
measured r¢liably.
Investment gains and losses..
This includes any realised or unrealised gains or1055es on the sale of investments and any
gain or loss resulting from revaluing investmenls lo market value at the cnd of th¢ year.
Expenditure and liabilities
Liiibilily recognition-.
Liabilitie5 are recognised when it is more likely than not thai there is a legal or consiruclive
obligation commilling ihe charity lo pay out resources and the amouni of the obligalion can be
measured wilh reasonable certainly.
Governance and support costs:
Support costs have been allocated between governance and other support.
Gov¢rnancc costs comprise all costs Invol￿1ng public accounlabiliiy of the charity and its
compliance wilh regulation and good practice.
Support costs include central functions and are allocated io a¢livily c051 categories on a basis
consistent with Ihe use of resources.
Grants payable without perforniance conditions=
Where thcrc are no perfonnance condilions attaching to Ihe grant payable. that enables the
charity lo realistically avoid the commilment. a liability for the full funding obligation is
recognised.

rNTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Page 10
Notes to the financial statements for the year ended 31 December 2020 (Continued)
Accounting policies {eontinued)
Creditors:
Creditors are measured al settlemenl amounts. Value Added Tax is not ￿0Verable by the
charity, and as such is included in ihe relevanl cosis.
Assets
Investments:
Fixed asset investments in quoted shares, traded bonds and similar investmen15 are valued
initially al cost and subsequently at fair value {their market value) al the year end.
Debtors..
Debtors are measured on initial recognition at settlement amouni. Subsequently, they are
measured al the cash or other consideraiion expecied to be received.
Current asset investmenls.
The ¢harily has cash deposits with a maturity of 1¢$$ than one year, held for investmenl
purposes raiher than lo meer shon ierm cash commitments as they fall due.
Income from charitable activities
In¢omc from charitable actii'ilies repr¢s¢nts the company's share of profit from the publication
of the Journal, as shown in the accounts produced by tlie Publisher. after deducting non
rechargeable Editorial costs.
The cu￿ent publishing agreement imposes a maximum annual limit on Edilorial costs
inCu￿ed by the company that can b¢ charged to the Publisher. In return, the company receives
a guaranteed profit share equivalent to 8IP/o of the profit share paid to the company for the
previous year.
2020
2019
Share of profit
Ediiorial costs not recharged
41,084
(30}
41,787
(2,707)
41,054
39.080
Income from investments
2020
2019
Dividends from investment portfolio
Inierest on bank deposits
27.112
1,989
36,792
2.081
29.101
38,873

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Pagc 11
Notes to the financial statements for the )'ear ended 31 December 2020 {con(inlled)
Research fellowship grants and priies
2020
2019
Institutional grants-
Fellowship for MB PhD studies=
University of Cambridge
University College London
Institutional prizes and lectures:
British Society for Matrix Biology
Fell Muir award and iravel costs
UCL Woolf prize
Brazil conference guest speaker subsidy
88,032
81.193
1,200
,433
1,000
600
800
1,000
172,858
1,400
Governance costs
2020
2019
Fee for independent examiner
Other governance costs
900
10.550
900
10.357
11.450
11,257
The Trustees receiv¢d no remuneration or reimbursed expenses during the year. Travelling
expenses amounting to £2,51 O wer¢ reimbursed io four Truslees in 2019. There are no
employees.
Investment assets
Fixed asset investments
Carrying (fair) value at l January 2020
Additions al cost
Disposals at maikct value
1,014,411
57,709
(52,441)
1,019.679
40,998
Increase in market value for the year
Carrying (fair) value dt 31 December 2020
1,060,677
The historical cost of listed inveslmenls is £729,507 (2019 £717,077)
Current asset investments
2020
2019
Cash deposits with a maturity of less than one year
180,000
134,000

tNTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
Pag¢ 12
Notes to the financial sta¢ements lor the year ended 31 December 2020 (continued)
Debtors
2020
2018
Trade debtors
Other debiors
58.478
26,972
55,860
33,857
85,450
89,717
Creditors". amounts falling duc
within one year
2020
2019
Accruals
179.988
75,285
Creditors: amounts falling due
aftcr more than one ycar
2020
2019
Accrual for Fellowships awarded
113,188
26,396
10. Movement in funds
General Fair value
Fund
reserve
Total
Funds
Ai l January 2020
Nel expenditure for the year
Realised and unrealised gainl(loss) on investments
Transfer of surplus relating to investments sold
1,048.590 297,334 1,345,924
(114,153)
(114,153)
{1,191)
39,807
7.162
40.998
(7,162)
Ai 31 December 2020
940,408 331,170 1,271,578